Notice Number: NOT-NS-18-030

Key Dates
Release Date: December 18, 2017

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to inform applications that as of the February 16, 2018, standard due date, NINDS will no longer participate in the Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) (PA-18-286), and will not accept any applications to the Funding Opportunity Announcement (FOA) PA18-286.
Currently reads:

Components of Participating Organizations
National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.853; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279; 93.846

Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
IC Specific Guidelines
The following text has been removed:

NINDS: For applications relevant to the mission (http://www.ninds.nih.gov/about_ninds/mission.htm) of the National Institute for Neurological Disorders and Stroke (NINDS): NINDS will not accept applications under this announcement that include clinical trials (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html). A clinical trial is a prospective biomedical or behavioral research study of human subjects designed to answer specific questions about safety, tolerability, efficacy and/or effectiveness of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions. Other human subjects research can be submitted and NINDS may decline funding of any application that includes human subjects for programmatic or administrative reasons. Applicants considering projects involving human subjects research are strongly encouraged to contact Scientific/Research staff.

Modified to read:

Components of Participating Organizations
National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279; 93.846

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Nick Langhals, Ph.D.
National Institute of Neurological Disorders and Stroke
Telephone: 301-496-1447
Email: nick.langhals@nih.gov